EP4316521
ANTI-HER2 ANTIBODY DRUG CONJUGATE PHARMACEUTICAL PREPARATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.3.2020EP published:
18.6.2025EP application number:
23202349.9
EPO information:
European Patent Register
Max expiry date:
24.3.2040
Title in English:
ANTI-HER2 ANTIBODY DRUG CONJUGATE PHARMACEUTICAL PREPARATIONLanguage of the patent:
English
Timeline
Today
25.3.2020EP application
18.6.2025EP Publication
Owner
Name:
RemeGen Co., Ltd.Address:
China (Shandong) Pilot Free Trade Zone Yantai District, Yantai Development Zone No.58 Beijing Middle Road, Shandong 264006, CN
Inventor
Name:
LI, ZhuanglinAddress:
Shandong, 264006, CN
Name:
XU, QiaoyuAddress:
Shandong, 264006, CN
Name:
YAO, XuejingAddress:
Shandong, 264006, CN
Name:
BAO, QianjingAddress:
Shandong, 264006, CN
Name:
FANG, JianminAddress:
Shandong, 264006, CN
Priority
Number:
201910231203Date:
26.3.2019Country:
CN
Classification
Categories:
A61K 47/68, A61K 47/65, A61K 9/19, A61P 35/00, A61K 9/08, A61K 38/00, A61K 39/395, A61K 47/20